Evidence map›Paper›PMID 15339043›Full record

ReviewJournal of molecular histology2004

CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion.

Magda Kucia, Kacper Jankowski, Ryan Reca, Marcin Wysoczynski, Laura Bandura, Daniel J Allendorf, Jin Zhang, Janina Ratajczak, Mariusz Z Ratajczak

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of molecular histology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 307 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
307citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

307 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Macrophages orchestrate tail regeneration in lizardsFrontiers in cell and developmental biology · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Immunomodulatory Delivery Materials for Tissue Repair.Advanced healthcare materials · 2025
    Review
  14. Review
  15. Article
  16. Review
  17. CXCR4 Is a Potential Target for Anti-HIV Gene Therapy.International journal of molecular sciences · 2024
    Review
  18. Article
  19. Article
  20. Article

247 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Magda KuciaStem Cell Biology Program, James Graham Brown Cancer Center, University of Louisville, KY 40202, USA.
Kacper Jankowski
Ryan Reca
Marcin Wysoczynski
Laura Bandura
Daniel J Allendorf
Jin Zhang
Janina Ratajczak
Mariusz Z Ratajczak

Funding

CELLULAR AND MOLECULAR BASIS OF HIV BASED THROMBOCYTOPENR01HL061796 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI RATAJCZAK, MARIUSZ Z · 1998 to 2002
$926k
NHLBI NIH HHS R01 HL61796-01
6 · The paper itself

Abstract

Chemokines, small pro-inflammatory chemoattractant cytokines, that bind to specific G-protein-coupled seven-span transmembrane receptors present on plasma membranes of target cells are the major regulators of cell trafficking. In addition some chemokines have been reported to modulate cell survival and growth. Moreover, compelling evidence is accumulating that cancer cells may employ several mechanisms involving chemokine-chemokine receptor axes during their metastasis that also regulate the trafficking of normal cells. Of all the chemokines, stromal-derived factor-1 (SDF-1), an alpha-chemokine that binds to G-protein-coupled CXCR4, plays an important and unique role in the regulation of stem/progenitor cell trafficking. First, SDF-1 regulates the trafficking of CXCR4+ haemato/lymphopoietic cells, their homing/retention in major haemato/lymphopoietic organs and accumulation of CXCR4+ immune cells in tissues affected by inflammation. Second, CXCR4 plays an essential role in the trafficking of other tissue/organ specific stem/progenitor cells expressing CXCR4 on their surface, e.g., during embryo/organogenesis and tissue/organ regeneration. Third, since CXCR4 is expressed on several tumour cells, these CXCR4 positive tumour cells may metastasize to the organs that secrete/express SDF-1 (e.g., bones, lymph nodes, lung and liver). SDF-1 exerts pleiotropic effects regulating processes essential to tumour metastasis such as locomotion of malignant cells, their chemoattraction and adhesion, as well as plays an important role in tumour vascularization. This implies that new therapeutic strategies aimed at blocking the SDF-1-CXCR4 axis could have important applications in the clinic by modulating the trafficking of haemato/lymphopoietic cells and inhibiting the metastatic behaviour of tumour cells as well. In this review, we focus on a role of the SDF-1-CXCR4 axis in regulating the metastatic behaviour of tumour cells and discuss the molecular mechanisms that are essential to this process.

Indexed as

Signal TransductionAnimalsCell AdhesionCell MovementChemokine CXCL12Chemokines, CXCChemotaxisHumansNeoplasm MetastasisNeoplasmsReceptors, CXCR4Chemokine CXCL12Chemokines, CXCCXCL12 protein, humanReceptors, CXCR4

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.